These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 16839359

  • 1. Characterization of bitiscetin-2, a second form of bitiscetin from the venom of Bitis arietans : comparison of its binding site with the collagen-binding site on the von Willebrand factor A3-domain.
    Obert B, Romijn RA, Houllier A, Huizinga EG, Girma JP.
    J Thromb Haemost; 2006 Jul; 4(7):1596-601. PubMed ID: 16839359
    [Abstract] [Full Text] [Related]

  • 2. Conformational changes in the A3 domain of von Willebrand factor modulate the interaction of the A1 domain with platelet glycoprotein Ib.
    Obert B, Houllier A, Meyer D, Girma JP.
    Blood; 1999 Mar 15; 93(6):1959-68. PubMed ID: 10068669
    [Abstract] [Full Text] [Related]

  • 3. Bitiscetin-3, a Novel C-Type Lectin-like Protein Cloned from the Venom Gland of the Viper Bitis arietans, Induces Platelet Agglutination and Inhibits Binding of Von Willebrand Factor to Collagen.
    Nashimoto Y, Matsushita F, Dijkstra JM, Nakamura Y, Akiyama H, Hamako J, Morita T, Araki S, Matsui T.
    Toxins (Basel); 2022 Mar 25; 14(4):. PubMed ID: 35448845
    [Abstract] [Full Text] [Related]

  • 4. Binding site on human von Willebrand factor of bitiscetin, a snake venom-derived platelet aggregation inducer.
    Matsui T, Hamako J, Matsushita T, Nakayama T, Fujimura Y, Titani K.
    Biochemistry; 2002 Jun 25; 41(25):7939-46. PubMed ID: 12069583
    [Abstract] [Full Text] [Related]

  • 5. Crystal structure of von Willebrand factor A1 domain complexed with snake venom, bitiscetin: insight into glycoprotein Ibalpha binding mechanism induced by snake venom proteins.
    Maita N, Nishio K, Nishimoto E, Matsui T, Shikamoto Y, Morita T, Sadler JE, Mizuno H.
    J Biol Chem; 2003 Sep 26; 278(39):37777-81. PubMed ID: 12851390
    [Abstract] [Full Text] [Related]

  • 6. Purification and characterization of bitiscetin, a novel von Willebrand factor modulator protein from Bitis arietans snake venom.
    Hamako J, Matsui T, Suzuki M, Ito M, Makita K, Fujimura Y, Ozeki Y, Titani K.
    Biochem Biophys Res Commun; 1996 Sep 04; 226(1):273-9. PubMed ID: 8806626
    [Abstract] [Full Text] [Related]

  • 7. Crystal structure of bitiscetin, a von Willebrand factor-dependent platelet aggregation inducer.
    Hirotsu S, Mizuno H, Fukuda K, Qi MC, Matsui T, Hamako J, Morita T, Titani K.
    Biochemistry; 2001 Nov 13; 40(45):13592-7. PubMed ID: 11695907
    [Abstract] [Full Text] [Related]

  • 8. Structure and function of snake venom toxins interacting with human von Willebrand factor.
    Matsui T, Hamako J.
    Toxicon; 2005 Jun 15; 45(8):1075-87. PubMed ID: 15922776
    [Abstract] [Full Text] [Related]

  • 9. von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagen.
    Bonnefoy A, Romijn RA, Vandervoort PA, VAN Rompaey I, Vermylen J, Hoylaerts MF.
    J Thromb Haemost; 2006 Oct 15; 4(10):2151-61. PubMed ID: 16805860
    [Abstract] [Full Text] [Related]

  • 10. Molecular modeling of ligand and mutation sites of the type A domains of human von Willebrand factor and their relevance to von Willebrand's disease.
    Jenkins PV, Pasi KJ, Perkins SJ.
    Blood; 1998 Mar 15; 91(6):2032-44. PubMed ID: 9490688
    [Abstract] [Full Text] [Related]

  • 11. The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen.
    Morales LD, Martin C, Cruz MA.
    J Thromb Haemost; 2006 Feb 15; 4(2):417-25. PubMed ID: 16420575
    [Abstract] [Full Text] [Related]

  • 12. Structure and function of snake venom proteins affecting platelet plug formation.
    Matsui T, Hamako J, Titani K.
    Toxins (Basel); 2010 Jan 15; 2(1):10-23. PubMed ID: 22069544
    [Abstract] [Full Text] [Related]

  • 13. A consensus tetrapeptide selected by phage display adopts the conformation of a dominant discontinuous epitope of a monoclonal anti-VWF antibody that inhibits the von Willebrand factor-collagen interaction.
    Vanhoorelbeke K, Depraetere H, Romijn RA, Huizinga EG, De Maeyer M, Deckmyn H.
    J Biol Chem; 2003 Sep 26; 278(39):37815-21. PubMed ID: 12855711
    [Abstract] [Full Text] [Related]

  • 14. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
    Hillery CA, Mancuso DJ, Evan Sadler J, Ponder JW, Jozwiak MA, Christopherson PA, Cox Gill J, Paul Scott J, Montgomery RR.
    Blood; 1998 Mar 01; 91(5):1572-81. PubMed ID: 9473222
    [Abstract] [Full Text] [Related]

  • 15. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
    De Luca M, Facey DA, Favaloro EJ, Hertzberg MS, Whisstock JC, McNally T, Andrews RK, Berndt MC.
    Blood; 2000 Jan 01; 95(1):164-72. PubMed ID: 10607699
    [Abstract] [Full Text] [Related]

  • 16. The interaction of the von Willebrand factor-A1 domain with platelet glycoprotein Ib/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein.
    Cruz MA, Handin RI, Wise RJ.
    J Biol Chem; 1993 Oct 05; 268(28):21238-45. PubMed ID: 8407961
    [Abstract] [Full Text] [Related]

  • 17. Structure-Based Cyclic Glycoprotein Ibα-Derived Peptides Interfering with von Willebrand Factor-Binding, Affecting Platelet Aggregation under Shear.
    Hrdinova J, Fernández DI, Ercig B, Tullemans BME, Suylen DPL, Agten SM, Jurk K, Hackeng TM, Vanhoorelbeke K, Voorberg J, Reutelingsperger CPM, Wichapong K, Heemskerk JWM, Nicolaes GAF.
    Int J Mol Sci; 2022 Feb 12; 23(4):. PubMed ID: 35216161
    [Abstract] [Full Text] [Related]

  • 18. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
    Stepanian A, Ribba AS, Lavergne JM, Fressinaud E, Juhan-Vague I, Mazurier C, Girma JP, Meyer D.
    Br J Haematol; 2003 Feb 12; 120(4):643-51. PubMed ID: 12588351
    [Abstract] [Full Text] [Related]

  • 19. Binding of the von Willebrand factor A1 domain to histone.
    Ward CM, Tetaz TJ, Andrews RK, Berndt MC.
    Thromb Res; 1997 Jun 15; 86(6):469-77. PubMed ID: 9219327
    [Abstract] [Full Text] [Related]

  • 20. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
    Martin C, Morales LD, Cruz MA.
    J Thromb Haemost; 2007 Jul 15; 5(7):1363-70. PubMed ID: 17389010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.